| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Amyloid involvement in subcortical regions predicts cognitive decline
|
Cho, Soo Hyun
|
|
2018
|
45 |
13 |
p. 2368-2376
|
artikel
|
| 2 |
A risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score
|
Yhim, Ho-Young
|
|
2018
|
45 |
13 |
p. 2274-2284
|
artikel
|
| 3 |
Clinical translation of [18F]ICMT-11 for measuring chemotherapy-induced caspase 3/7 activation in breast and lung cancer
|
Dubash, S. R.
|
|
2018
|
45 |
13 |
p. 2285-2299
|
artikel
|
| 4 |
Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET/CT, SPECT/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging study
|
Antwi, Kwadwo
|
|
2018
|
45 |
13 |
p. 2318-2327
|
artikel
|
| 5 |
Correction to: A rare presentation of skull-base osteomyelitis with neurovascular sheath extension following external otitis resolved by PET/MRI
|
Louarn, Nicolas
|
|
2018
|
45 |
13 |
p. 2480-2481
|
artikel
|
| 6 |
Correction to: a risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score
|
Yhim, Ho-Young
|
|
2018
|
45 |
13 |
p. 2482-2483
|
artikel
|
| 7 |
Correlation of dose with toxicity and tumour response to 90Y- and 177Lu-PRRT provides the basis for optimization through individualized treatment planning
|
Cremonesi, Marta
|
|
2018
|
45 |
13 |
p. 2426-2441
|
artikel
|
| 8 |
Disease-related patterns of in vivo pathology in Corticobasal syndrome
|
Niccolini, Flavia
|
|
2018
|
45 |
13 |
p. 2413-2425
|
artikel
|
| 9 |
Distinct [18F]THK5351 binding patterns in primary progressive aphasia variants
|
Schaeverbeke, Jolien
|
|
2018
|
45 |
13 |
p. 2342-2357
|
artikel
|
| 10 |
EANM practical guidance on uncertainty analysis for molecular radiotherapy absorbed dose calculations
|
Gear, Jonathan I.
|
|
2018
|
45 |
13 |
p. 2456-2474
|
artikel
|
| 11 |
EANM Springer Prizes awarded at EANM’18 in Düsseldorf
|
|
|
2018
|
45 |
13 |
p. 2478-2479
|
artikel
|
| 12 |
Early treatment response evaluation using FET PET compared to MRI in glioblastoma patients at first progression treated with bevacizumab plus lomustine
|
Galldiks, Norbert
|
|
2018
|
45 |
13 |
p. 2377-2386
|
artikel
|
| 13 |
Hypermetabolism in the cerebellum and brainstem and cortical hypometabolism are independently associated with cognitive impairment in Parkinson’s disease
|
Blum, Dominik
|
|
2018
|
45 |
13 |
p. 2387-2395
|
artikel
|
| 14 |
I-131 as adjuvant treatment for differentiated thyroid carcinoma may cause an increase in the incidence of secondary haematological malignancies: an “inconvenient” truth?
|
Verburg, Frederik A.
|
|
2018
|
45 |
13 |
p. 2247-2249
|
artikel
|
| 15 |
Lale Umutlu, Ken Herrmann (Eds.). PET/MR Imaging: Current and Emerging Applications
|
Mansi, Luigi
|
|
2018
|
45 |
13 |
p. 2485
|
artikel
|
| 16 |
Local and whole-body staging in patients with primary breast cancer: a comparison of one-step to two-step staging utilizing 18F-FDG-PET/MRI
|
Kirchner, Julian
|
|
2018
|
45 |
13 |
p. 2328-2337
|
artikel
|
| 17 |
NaF uptake in unstable plaque: what does fluoride uptake mean?
|
Nakahara, Takehiro
|
|
2018
|
45 |
13 |
p. 2250-2252
|
artikel
|
| 18 |
Nuclear medicine RIP (radiation induced phobia); improving the image
|
McCready, V. Ralph
|
|
2018
|
45 |
13 |
p. 2475-2477
|
artikel
|
| 19 |
PISCOM: a new procedure for epilepsy combining ictal SPECT and interictal PET
|
Perissinotti, Andrés
|
|
2018
|
45 |
13 |
p. 2358-2367
|
artikel
|
| 20 |
Prostate-specific antigen flare induced by 223RaCl2 in patients with metastatic castration-resistant prostate cancer
|
Castello, Angelo
|
|
2018
|
45 |
13 |
p. 2256-2263
|
artikel
|
| 21 |
223Ra-Dichloride in castration-resistant metastatic prostate cancer: improving outcomes and identifying predictors of survival in clinical practice
|
Dizdarevic, Sabina
|
|
2018
|
45 |
13 |
p. 2264-2273
|
artikel
|
| 22 |
Radiomics analysis of pre-treatment [18F]FDG PET/CT for patients with metastatic colorectal cancer undergoing palliative systemic treatment
|
Helden, E. J. van
|
|
2018
|
45 |
13 |
p. 2307-2317
|
artikel
|
| 23 |
Serial FLT PET imaging to discriminate between true progression and pseudoprogression in patients with newly diagnosed glioblastoma: a long-term follow-up study
|
Brahm, Cyrillo G.
|
|
2018
|
45 |
13 |
p. 2404-2412
|
artikel
|
| 24 |
The influence of PSA flare in mCRPC patients treated with alpha-emitting radiopharmaceuticals
|
Ceci, Francesco
|
|
2018
|
45 |
13 |
p. 2253-2255
|
artikel
|
| 25 |
The prognostic value of [123I]-vascular endothelial growth factor ([123I]-VEGF) in glioma
|
Rainer, Eva
|
|
2018
|
45 |
13 |
p. 2396-2403
|
artikel
|
| 26 |
The renaissance of functional 18F-FDG PET brain activation imaging
|
Verger, Antoine
|
|
2018
|
45 |
13 |
p. 2338-2341
|
artikel
|
| 27 |
Translational molecular imaging in exocrine pancreatic cancer
|
Cornelissen, Bart
|
|
2018
|
45 |
13 |
p. 2442-2455
|
artikel
|
| 28 |
U. Fischer, F. Baum, S. Luftner-Nagel. Breast Cancer: Diagnostic Imaging and Therapeutic Guidance
|
Vultaggio, Viola
|
|
2018
|
45 |
13 |
p. 2484
|
artikel
|
| 29 |
89Zr-trastuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work up
|
Bensch, Frederike
|
|
2018
|
45 |
13 |
p. 2300-2306
|
artikel
|
Tijdschrift beschrijving